Tag - prescription therapy

Feature

Ritter Pharma aims to have first FDA-approved treatment for lactose intolerance

By Len Zehr Ritter Pharmaceuticals’ (NASDAQ:RTTR) lead product candidate, RP-G28, which recently entered Phase 3 clinical trials, has the potential to become the first prescription therapy for lactose intolerance, a...

September 4, 2018

Tag - prescription therapy

Ritter Pharma aims to have first FDA-approved treatment for lactose intolerance

General

More